Atlas Trials

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

Clinical trial NCT02619747 · TERMINATED

Trial details

NCT number
NCT02619747
Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastro-esophageal Reflux Disease (GERD)
Start date
2014-04-01
Primary completion
2017-03-31
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.